Digital Signatures For Life Sciences Presented In ARX Webinar
ARX to present on the use of digital signatures within the Life Sciences industry, including common applications, legal and compliance issues, benefits and best practices.
- (1888PressRelease) July 09, 2010 - San Francisco, California - In an upcoming webinar titled How to Streamline Clinical Operations with Digital Signatures, Rodd Schlerf, Life Sciences Market Manager at ARX (a leading provider of digital signature solutions) will present on the use and benefits of digital signatures in Life Sciences. Topics will include the common clinical applications where digital signatures can bring value, as well as regulatory compliance issues, case studies and best practices.
Register now for the free webinar, which takes place Wed July 21, 2010 at 1:00 PM (EDT).
The Life Sciences industry has witnessed a growing trend of digital signature adoption as an enabler of secure electronic document transferability among clinical investigators, clinical research organizations, sponsors, regulators, etc. Some organizations, like ClinPhone (a subsidiary of PAREXEL) have adopted digital signatures to meet FDA 21 CRF part 11 regulations. Others use digital signatures within investigator portals and clinical trial management systems, as well as processes such as site monitoring trip reports, the initiation of clinical sites, and the signing of documents used in FDA, EMEA, and Vendor audits.
While electronic signatures bind signers to proprietary systems (thereby prohibiting non-users of the system from verifying the signature), over 10,000 Life Sciences organizations have adopted the CoSignŽ digital signature solution, which, based on PKI (Public Key Infrastructure) technology, enables any third party to verify the digital signature for signer identity and intent, and content integrity. Equipped with this digital signing technology, these organizations are able to replace slow and expensive paper-based approval processes with fast, low-cost, and fully digital ones. Consequently, they gain measurable organizational improvements such as expedited processes and significantly reduced costs.
About CoSign Digital Signatures in Life Sciences :
ARX (Algorithmic Research) is a global provider of cost-efficient digital signature solutions for industries such as life sciences, healthcare, government, engineering, and energy. ARX's CoSign digital signature solution fully automates approval workflows, allowing organizations to go paperless, expedite business processes, and eliminate the expenses and time allocations that paper-based signatures require. CoSign is the most widely-deployed digital signature solution in the Life Sciences industry, employed by over 10,000 FDA-regulated organizations including 5 of the top 10 Pharmaceuticals and 4 of the top 10 CROs. Via its standards-based underpinnings, the CoSign digital signature solution ensures signer intent, document integrity and compliance, while significantly streamlining business processes. CoSign creates a truly collaborative environment for the multiple parties involved in the Life Sciences ecosystem, enabling trust of electronic documentation spanning geographic locations and across organizations. Watch a Digital Signatures for Life Sciences video to learn how life sciences organizations can benefit from CoSign.
CoSign is a registered trademark of Algorithmic Research, Ltd. All other trade names and trademarks are the property of their respective holders.
###
space
space
Contact Information
- Ashley Miller
- Arx
- 855 Folsom Street
Suite 939
- San Francisco, CA ,USA
- 94107
- Voice: (415) 839 8161
- Visit our Site
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam